Generation of two isogenic sickle cell disease induced pluripotent stem cell lines from ovarian fibroblasts
Mitchell R Harancher1, Livianna K Myklebust2, Meena Sukhwani3
1Molecular Genetics and Developmental Biology Graduate Program, University of Pittsburgh, PA, United States; Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh Medical Center, USA.
Abstract:
Curative bone marrow transplantation (BMT) therapies for sickle cell disease (SCD) can cause infertility. The Fertility Preservation Program (FPP) in Pittsburgh cryopreserves ovarian tissues for SCD patients prior to BMT in anticipation that these tissues can be used in the future to produce eggs and achieve a pregnancy. Here, we generated and validated two isogenic patient-derived induced pluripotent stem cell (iPSC) lines from ovarian cortex fibroblasts of a 28-year-old SCD patient.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
iPS Cell Differentiation
EPS and iPS Cells in Disease Research


